No Detail Found!

In silico Elucidation of Potent Therapeutic Targets against Alzheimer's by Targeting CAPNS2

Author(s)
Hassan Bin Waseem Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Musafa Mubeen Department of Biology, University of Okara,Okara,Pakistan
Muhammad Talal Rahim Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Muhammad Kazim Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Ayman Rashid Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Muhammad Sohaib Amir Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Ayesha Afzal Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics, the Islamia University of Bahawalpur, Bahawalpur, Pakistan
Sehrish Naz Department of Zoology, University of Okara,Okara,Pakistan
Abstract
Alzheimer's disease (AD) is considered one of the common types of dementia in which brain cells gradually deteriorate, leading to memory loss. Approximately 50 million people are afflicted by AD. There is no permanent solution for this malady; however, early detection may help slow down the disease prognosis. In the current study, a hybrid approach of molecular docking studies and virtual screening is taken to test compounds from the 'Zinc database library' that may be effective against AD by targeting CAPNS2. The top-ranked four compounds were reported by molecular docking analysis on the basis of their binding affinity by targeting CAPNS2. Molecular docking analyses revealed that Lys-5, Ala-4, Leu-3, Tyr-56, Ile-48, Ala-52, Gln-55, Cys-56, Ala152, Ala-54, and Ala-53 are the interacting residues from the selected target protein. In addition, the absorption, distribution, metabolism, excretion, and toxicity (ADMET) analyses were performed to assess the drug-like properties of the selected compounds. After extensive in silico analyses, the present study deduced that the top four scrutinized compounds might be potent against AD by targeting CAPNS2. .
Publication Details
Page(s) 125-138
Published Journal: Molecular Medicine Communications, Volume: 3, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Alzheimer's Disease, Bioinformatics, Virtual screening, computational drug design, CAPNS2
0

Citations

0

Downloads

35

Views